Investment - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) (OWP Ventures, Inc.) - OWP Ventures, Inc. [Member] - USD ($) |
Nov. 30, 2018 |
Nov. 22, 2018 |
|||
---|---|---|---|---|---|
Consideration: Cash paid at closing | $ 350,000 | $ 350,000 | |||
Consideration: Accounts payable | 198 | ||||
Consideration: Fair value of total consideration exchanged | 350,198 | ||||
Fair value of identifiable assets acquired assumed: Other current assets | 778 | ||||
Fair value of identifiable assets acquired assumed: Total fair value of assets assumed | 778 | ||||
Fair value of identifiable assets acquired assumed: Consideration paid in excess of fair value (Goodwill) | $ 349,420 | $ 349,420 | [1] | ||
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of assets acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|